The discussion on PAD treatment through clinical cases and debates were the motor of the interaction at the iVS 2020.
Madrid, Spain, February 28th, 2020.
Vascular surgeons, radiologists and angiologists from all Europe, Middle East, Asia, and Latino America, joined the interactive Vascular Summit (iVS) from 27th to 28th of February, in Spain.
This interactive summit had the intention to update on the latest trials, technologies, and devices for PAD treatment.
“We are really proud to welcome and embrace 126 worldwide physicians in our first iVS edition,” said Natalia Paris (Marketing Director of iVascular).
iVS’s scientific committee is conformed by Dr. Koen Deloose (Belgium), Dr. Fabrizio Fanelli (Italy), Prof. Yann Goüeffic (France), Dr. Ralf Langhoff (Germany) and Prof. Vicente Riambau (Spain).
The scientific committee has carefully structured the content, to achieve dynamic and educational sessions.
This program has been divided into three main subjects: iliac, femoropopliteal and BTK treatment.
Iliac session of iVS
During the iliac session of iVS, physicians discussed the practice of open surgery vs endovascular surgery for the treatment of iliac arteries.
The majority of attendees confirmed that they use open surgery in less than 50% of cases, in their daily practice.
Later that day, Dr Fabrizio Fanelli and Prof Ulf Teichgräber discussed the use of DCB, during the femoropopliteal session. After their presentation, 75% of attendees concluded that the use of DCB is still the option that provides the greatest benefit for patient treatment.
“The commitment with innovation that we have as iVascular, goes further than device development, we also want to innovate on the scientific and educational areas,” Said Albert Jávega (Deputy Managing Director of iVascular).
iVascular has designed the iVS with the main objective of creating a scientific and interactive meeting regarding PAD treatment.
The scientific committee have been focused on improve the knowledge and ensure that it can help the attendees to continue taking the best decisions for their patients.